Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
Relates to the menstrual product safety and research act and its creation of a research program to determine the risks posed from potential toxins in menstrual products.
Establishes the fibroid study fund to expend moneys to the department of health to study fibroids, the treatment of fibroids, potential barriers to the access of treatment for fibroids, and differences in symptoms and access to treatment for women of color.
Relates to the publication of immunization information; requires schools to provide immunization information to the commissioner of health; requires the department of health to make immunization information, including rates of immunization, available on its website.
Directs the department of health to develop and implement a residency program initiative to service medically underserved areas; makes an appropriation therefor.
Relates to directing the department of health to study the potential health risks and effects of glyphosate and its by-product aminomethylphosphonic acid; requires the commissioner of health to prepare a report for the governor and the legislature that includes the findings of such study, and to conduct an outreach program to inform local governments, private organizations, schools and the public regarding the findings of such report.
Relates to disputes between a surrogate and a hospital or individual health care provider; cites when the requirement of a provider to provide life-sustaining treatment following a surrogate's directive does not apply.